Page last updated: 2024-11-07

prednisone and Uveomeningoencephalitic Syndrome

prednisone has been researched along with Uveomeningoencephalitic Syndrome in 43 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Uveomeningoencephalitic Syndrome: A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta (a strand of depigmented hair), HEARING DISORDERS, and meningeal signs (neck stiffness and headache). Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. (Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39(4):265-292)

Research Excerpts

ExcerptRelevanceReference
"Case report of a patient with Vogt-Koyanagi-Harada disease on prednisone, with acute clinical changes suspicious for bilateral tuberculous choroiditis."4.02TUBERCULOUS CHOROIDITIS IN PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE. ( Anderson, EW; El Khoury, L; Goldberg, NR; Jonisch, J; Schwartzman-Morris, JS, 2021)
"Intensive and prolonged systemic treatment with corticosteroids is recommended for the patients with first attack of VKH syndrome, where as regular treatment with chlorambucil is useful for control of chronic and recurrent uveitis seen in VKH syndrome."3.71[Therapeutic regimen in Vogt-Koyanagi-Harada syndrome]. ( Fu, T; Huang, X; Li, F; Wang, H; Yang, P; Zhong, H; Zhou, H, 2002)
"A brazilian housewife, descendant of japanese (both parents), 37 years aged, affected with Vogt-Koyanagi's syndrome (uveitis, dysacousia, alopecia, madarosis, poliosis, vitiligo) was treated with prednisone."3.66[Vogt-Koyanagi syndrome. Therapeutic trial with corticosteroid]. ( Curban, GV; Kayano, T; Vieira Filho, E, 1979)
"The visual results, frequency of recurrence of uveitis and incidence of ocular complications were compared between the two groups."2.70[Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis]. ( Du, H; Hu, T; Liu, Q; Min, H; Zhang, M, 2002)
"Oral prednisone was gradually tapered off by a diminished dose according to a relatively strict protocol."1.91HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT-KOYANAGI-HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN. ( Cheng, Z; Li, H; Li, X; Liu, T; Tao, Q; Wang, K; Zhang, M; Zhang, X; Zhao, G; Zheng, C, 2023)
"He was found to have bilateral optic disc edema (ODE) and peripapillary subretinal fluid and was initially investigated for causes of raised intracranial pressure."1.62Headache and Bilateral Optic Disc Edema as the Initial Manifestation of Vogt-Koyanagi-Harada Disease. ( Christakis, PG; Micieli, JA; Nichani, P, 2021)
"We describe a 55-year-old male IgA nephropathy patient who was admitted with high fever and hematuria."1.56A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome. ( Fan, X; Han, H; Tian, M; Zhang, Q, 2020)
"To investigate the effectiveness, visual outcome, and prognostic factors of Vogt-Koyanagi-Harada (VKH) disease treatment with a reduced dose of corticosteroids combined with immunosuppressive agents."1.48Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. ( Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q, 2018)
"To evaluate the effectiveness and safety of mycophenolate mofetil (MMF) as first-line therapy combined with systemic corticosteroids in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease."1.46Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. ( Abu El-Asrar, AM; Al-Muammar, A; Dosari, M; Gikandi, PW; Hemachandran, S, 2017)
"To analyse the rate of clinical recurrences in Brazilian patients with Vogt-Koyanagi-Harada (VKH) disease after early high-dose corticosteroid treatment."1.42High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. ( Costa, RA; da Silva, FT; Hirata, CE; Kalil, J; Marin, ML; Rodrigues, H; Sakata, VM; Yamamoto, JH, 2015)
"To study the effectiveness of mycophenolate mofetil (MMF) as first-line therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease."1.38The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. ( Abu El-Asrar, AM; Al-Mezaine, HS; Al-Muammar, AM; Hemachandran, S; Kangave, D, 2012)
"The case of VKH syndrome affecting Polish girl is very rare."1.33[The Vogt-Koyanagi-Harada syndrome in 11-year-old girl]. ( Mańkowska, A; Swiech-Zubilewicz, A; Wróblewska, E, 2005)
"The VKH syndrome has been reported to occur in association with other autoimmune disorders."1.32Vogt-Koyanagi-Harada syndrome and ulcerative colitis. ( Federman, DG; Judson, PH; Kirsner, RS; Kravetz, JD; Ruser, CB, 2004)

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19902 (4.65)18.7374
1990's6 (13.95)18.2507
2000's10 (23.26)29.6817
2010's20 (46.51)24.3611
2020's5 (11.63)2.80

Authors

AuthorsStudies
Wang, K1
Zheng, C1
Zhao, G1
Zhang, M2
Liu, T1
Li, H1
Tao, Q1
Cheng, Z1
Li, X1
Zhang, X1
Nichani, P1
Christakis, PG1
Micieli, JA1
Li, AS1
Tang, PH1
Do, DV1
Zhang, Q1
Fan, X1
Tian, M1
Han, H1
Urzua, CA2
Guerrero, J2
Gatica, H1
Velasquez, V2
Goecke, A2
Tsui, E1
Bottini, A1
Ghadiali, Q1
Balaratnasingam, C1
Barbazetto, I1
Yang, P2
Ye, Z1
Du, L1
Zhou, Q1
Qi, J1
Liang, L1
Wu, L1
Wang, C1
Kijlstra, A1
Birnbaum, FA1
Finn, AP1
Jaffe, GJ1
Anderson, EW1
El Khoury, L1
Schwartzman-Morris, JS1
Jonisch, J1
Goldberg, NR1
Chen, P1
Chaigne-Delalande, B1
Liu, B1
Anguita, R1
Sabat, P1
Sen, HN1
Lee, RWJ1
Caso, F1
Rigante, D1
Vitale, A1
Costa, L1
Bascherini, V1
Latronico, E1
Franceschini, R1
Cantarini, L1
Alp, A1
Akdam, H1
Akar, H1
Koseoglu, K1
Ozkul, A1
Meteoglu, I1
Yenicerioglu, Y1
Sakata, VM2
da Silva, FT2
Hirata, CE2
Marin, ML1
Rodrigues, H1
Kalil, J1
Costa, RA1
Yamamoto, JH2
Morita, C1
Rodriguez, EE1
Abdallah, SF1
Lavezzo, MM1
Machado, CG1
Oyamada, MK1
Abu El-Asrar, AM2
Dosari, M1
Hemachandran, S2
Gikandi, PW1
Al-Muammar, A1
Manethova, K1
Ernest, J1
Hrevus, M1
Vinh, T1
Elia, M1
Kawaguchi, T1
Horie, S1
Bouchenaki, N1
Ohno-Matsui, K1
Mochizuki, M1
Herbort, CP1
Cuchacovich, M1
Solanes, F1
Díaz, G1
Cermenati, T1
Avila, S1
Verdaguer, J1
Verdaguer, JI1
Carpentier, C1
Stopel, J1
Rojas, B1
Traipe, L1
Gallardo, P1
Sabugo, F1
Zanoli, M1
Merino, G1
Villarroel, F1
Tang, Y1
Wang, X1
Ding, Y1
Li, C1
Jia, J1
Lee, GE1
Lee, BW1
Rao, NA4
Fawzi, AA1
Arias, L1
Alcubierre, R1
Lorenzo, D1
Nazari, H1
Al-Mezaine, HS1
Kangave, D1
Al-Muammar, AM1
Sifuentes Giraldo, WA1
de la Puente Bujidos, C1
de Blas Beorlegui, G1
López San Román, A1
Peña Arrebola, A1
Wang, H1
Zhou, H1
Zhong, H2
Li, F1
Huang, X1
Fu, T1
Liu, Q1
Min, H1
Du, H1
Hu, T1
Tian'en, Z1
Libin, D1
Yushu, T1
BRONSTEIN, M1
Federman, DG1
Kravetz, JD1
Ruser, CB1
Judson, PH1
Kirsner, RS1
Kohnen, EM1
Pansdorf, Y1
Zubcov, A1
Swiech-Zubilewicz, A1
Wróblewska, E1
Mańkowska, A1
Goldstein, DA1
Tessler, HH2
Read, RW1
Yu, F1
Accorinti, M1
Bodaghi, B1
Chee, SP1
Fardeau, C1
Goto, H1
Holland, GN1
Kawashima, H1
Kojima, E1
Lehoang, P1
Lemaitre, C1
Okada, AA1
Pivetti-Pezzi, P1
Secchi, A1
See, RF1
Tabbara, KF1
Usui, M1
Cunningham, ET1
Demetrius, R1
Frieden, IJ1
Emery, HM1
Irvine, AR1
Good, WV1
Lepvrier-Guibal, N1
Korobelnik, JF1
Xuan, TH1
Wiesli, P1
Bernauer, W1
Furrer, J1
Mikou, O1
Chiheb, S1
Zouhair, K1
Jarmouni, RI1
Nejjam, F1
El Ouazzani, T1
Amraoui, A1
Lakhdar, H1
Garcia-Valenzuela, E1
Carnahan, M1
Ryan, JJ1
Oldstein, DA1
Curban, GV1
Kayano, T1
Vieira Filho, E1
Kätterer, C1
Kaeser, HE1
Steiger, U1
Forster, DJ1
Green, RL1
Johnston, CA1
Teitelbaum, CS1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study[NCT03399175]40 participants (Anticipated)Interventional2015-03-23Recruiting
Multimodal Analysis and Electroretinogram in VKH From Acute Onset - a Prospective Study[NCT03811366]12 participants (Actual)Interventional2011-06-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for prednisone and Uveomeningoencephalitic Syndrome

ArticleYear
Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Ocular immunology and inflammation, 2011, Volume: 19, Issue:1

    Topics: Acute Disease; Anti-Inflammatory Agents; Fluorescein Angiography; Fluorescence; Fundus Oculi; Humans

2011
[Vogt-Koyanagi-Harada disease complicated by subretinal neovessels].
    Journal francais d'ophtalmologie, 1995, Volume: 18, Issue:4

    Topics: Adult; Female; Humans; Prednisone; Retinal Detachment; Retinal Neovascularization; Uveomeningoenceph

1995
[Rare form of uveitis with neurological symptoms: the Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
    Schweizerische medizinische Wochenschrift, 1992, Feb-22, Volume: 122, Issue:8

    Topics: Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Middle Aged; P

1992

Trials

2 trials available for prednisone and Uveomeningoencephalitic Syndrome

ArticleYear
Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
    Ocular immunology and inflammation, 2010, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Dose-Respon

2010
[Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2002, Volume: 38, Issue:4

    Topics: Adolescent; Adult; Aged; Child; Female; Glucocorticoids; Humans; Male; Middle Aged; Prednisone; Prog

2002

Other Studies

38 other studies available for prednisone and Uveomeningoencephalitic Syndrome

ArticleYear
HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT-KOYANAGI-HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN.
    Retina (Philadelphia, Pa.), 2023, 09-01, Volume: 43, Issue:9

    Topics: Acute Disease; Disease Progression; Glucocorticoids; Humans; Immunosuppressive Agents; Prednisone; R

2023
Headache and Bilateral Optic Disc Edema as the Initial Manifestation of Vogt-Koyanagi-Harada Disease.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2021, 03-01, Volume: 41, Issue:1

    Topics: Adult; Diagnosis, Differential; Glucocorticoids; Headache; Humans; Male; Papilledema; Prednisone; Sl

2021
Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
    JAMA ophthalmology, 2020, 05-01, Volume: 138, Issue:5

    Topics: Administration, Oral; Blindness; Glucocorticoids; Headache; Humans; Infusions, Intravenous; Male; Me

2020
A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    BMC nephrology, 2020, 07-13, Volume: 21, Issue:1

    Topics: Cyclophosphamide; Fluorescein Angiography; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunos

2020
Evaluation of the Glucocorticoid Receptor as a Biomarker of Treatment Response in Vogt-Koyanagi-Harada Disease.
    Investigative ophthalmology & visual science, 2017, 02-01, Volume: 58, Issue:2

    Topics: Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Hum

2017
Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Ocular immunology and inflammation, 2018, Volume: 26, Issue:8

    Topics: Fluorescein Angiography; Glucocorticoids; Humans; Male; Middle Aged; Multimodal Imaging; Ophthalmosc

2018
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
    Current eye research, 2018, Volume: 43, Issue:2

    Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein

2018
Bilateral Retinal Detachments Presenting With Acute Angle Closure.
    JAMA ophthalmology, 2018, 08-01, Volume: 136, Issue:8

    Topics: Female; Fluorescein Angiography; Glaucoma, Angle-Closure; Glucocorticoids; Humans; Intraocular Press

2018
TUBERCULOUS CHOROIDITIS IN PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE.
    Retinal cases & brief reports, 2021, May-01, Volume: 15, Issue:3

    Topics: Adult; Antitubercular Agents; Choroiditis; Female; Glucocorticoids; Humans; Interferon-gamma Release

2021
Glucocorticoid Receptor-α and MKP-1 as Candidate Biomarkers for Treatment Response and Disease Activity in Vogt-Koyanagi-Harada Disease.
    American journal of ophthalmology, 2019, Volume: 207

    Topics: Adult; Biomarkers; Dual Specificity Phosphatase 1; Female; Gene Expression Regulation; Glucocorticoi

2019
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
    Clinical rheumatology, 2015, Volume: 34, Issue:10

    Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal;

2015
Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2014, Nov-17, Volume: 34, Issue:6

    Topics: Adult; Amaurosis Fugax; Aneurysm; Brain Edema; Celiac Artery; Combined Modality Therapy; Humans; Hyp

2014
High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:5

    Topics: Adolescent; Adult; Brazil; Child; Chronic Disease; Female; Fibrosis; Fluorescein Angiography; Glucoc

2015
Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease.
    Acta ophthalmologica, 2016, Volume: 94, Issue:8

    Topics: Administration, Oral; Adult; Biomarkers; Coloring Agents; Drug Combinations; Female; Fluorescein Ang

2016
Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Acta ophthalmologica, 2017, Volume: 95, Issue:1

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Disease Progression; Drug Therapy, Co

2017
Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
    European journal of ophthalmology, 2017, Jan-19, Volume: 27, Issue:1

    Topics: Adult; Choroid; Fluorescein Angiography; Glucocorticoids; Humans; Male; Ophthalmoscopy; Prednisone;

2017
Headaches and Blurry Vision.
    JAMA ophthalmology, 2017, 04-01, Volume: 135, Issue:4

    Topics: Adult; Fluorescein Angiography; Glucocorticoids; Headache; Humans; Male; Prednisone; Retinal Detachm

2017
Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.
    International ophthalmology, 2010, Volume: 30, Issue:1

    Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Choroid; Disease Progression;

2010
Longitudinal lesion of the spinal cord in a patient with Vogt-Koyanagi-Harada disease.
    Journal of neurology, neurosurgery, and psychiatry, 2010, Volume: 81, Issue:8

    Topics: Adolescent; Anti-Inflammatory Agents; Atrophy; Cyclophosphamide; Cyclosporine; Dysuria; Female; Huma

2010
[Bullous retinal detachment in chronic central serous chorioretinopathy treated with photodynamic therapy].
    Archivos de la Sociedad Espanola de Oftalmologia, 2011, Volume: 86, Issue:2

    Topics: Adult; Blister; Central Serous Chorioretinopathy; Chronic Disease; Cyclosporine; Diagnosis, Differen

2011
Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
    The British journal of ophthalmology, 2012, Volume: 96, Issue:11

    Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up S

2012
The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Acta ophthalmologica, 2012, Volume: 90, Issue:8

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Coloring Agents; Drug Therapy, Combin

2012
Herpes zoster motor neuropathy in a patient with previous motor paresis secondary to Vogt-Koyanagi-Harada disease.
    American journal of physical medicine & rehabilitation, 2013, Volume: 92, Issue:4

    Topics: Adult; Azathioprine; Colitis, Ulcerative; Disease Progression; Electromyography; Female; Herpes Zost

2013
[Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2002, Volume: 38, Issue:4

    Topics: Adolescent; Adult; Child; Chlorambucil; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Me

2002
Vogt-Koyanagi-Harada syndrome: report of a juvenile case.
    The Journal of dermatology, 2003, Volume: 30, Issue:7

    Topics: Child; China; Follow-Up Studies; Humans; Male; Prednisone; Rare Diseases; Risk Assessment; Severity

2003
Vogt-Koyanagi-Harada disease; treatment with prednisone.
    A.M.A. archives of ophthalmology, 1957, Volume: 57, Issue:4

    Topics: Humans; Prednisone; Uveitis; Uveomeningoencephalitic Syndrome

1957
Vogt-Koyanagi-Harada syndrome and ulcerative colitis.
    Southern medical journal, 2004, Volume: 97, Issue:2

    Topics: Adult; Alopecia; Colitis, Ulcerative; Glucocorticoids; Humans; Male; Prednisone; Uveomeningoencephal

2004
[Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2004, Volume: 101, Issue:4

    Topics: Azathioprine; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combin

2004
[The Vogt-Koyanagi-Harada syndrome in 11-year-old girl].
    Klinika oczna, 2005, Volume: 107, Issue:7-9

    Topics: Anti-Inflammatory Agents; Child; Female; Humans; Injections, Intravenous; Prednisone; Uveomeningoenc

2005
Ocular brucellosis vs Vogt-Koyanagi-Harada syndrome.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:4

    Topics: Anti-Bacterial Agents; Brucella; Brucellosis; Choroiditis; Dexamethasone; Doxycycline; Drug Therapy,

2006
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
    American journal of ophthalmology, 2006, Volume: 142, Issue:1

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Child; Female; Glucocorticoids; Humans

2006
Vogt-Koyanagi-Harada syndrome in a 4-year old child.
    American journal of ophthalmology, 1995, Volume: 120, Issue:5

    Topics: Alopecia; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Blindness; Child, Preschool;

1995
Headache and bilateral visual loss in a young hypothyroid Indian man.
    Journal of endocrinological investigation, 1999, Volume: 22, Issue:2

    Topics: Adult; Autoimmune Diseases; Headache; Humans; Hypothyroidism; Male; Prednisone; Thyroxine; Uveomenin

1999
[Vogt-Koyanagi-Harada's disease: 3 cases].
    Annales de dermatologie et de venereologie, 2000, Volume: 127, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Child; Diagnosis, Differential; Female; Follow-Up Studies; Humans;

2000
Multiple recurrences of exudative retinal detachment in a patient with Vogt-Koyanagi-Harada disease.
    Retina (Philadelphia, Pa.), 2000, Volume: 20, Issue:6

    Topics: Adult; Exudates and Transudates; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Hum

2000
[Vogt-Koyanagi syndrome. Therapeutic trial with corticosteroid].
    Medicina cutanea ibero-latino-americana, 1979, Volume: 7, Issue:1-3

    Topics: Adult; Drug Evaluation; Female; Humans; Pigmentation Disorders; Prednisone; Tablets; Uveitis; Uveome

1979
Unilateral manifestation of the Vogt-Koyanagi-Harada syndrome in a 7-year-old child.
    American journal of ophthalmology, 1991, Mar-15, Volume: 111, Issue:3

    Topics: Child; Fluorescein Angiography; Fundus Oculi; Humans; Male; Prednisone; Uveomeningoencephalitic Synd

1991
Magnetic resonance imaging in Vogt-Koyanagi-Harada syndrome.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1990, Volume: 108, Issue:6

    Topics: Administration, Oral; Adult; Chlorambucil; Diagnosis, Differential; Female; Humans; Magnetic Resonan

1990
chemdatabank.com